149 related articles for article (PubMed ID: 6253236)
1. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
[No Abstract] [Full Text] [Related]
2. Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
Chin Med J (Engl); 1980 Sep; 93(9):591-8. PubMed ID: 6253237
[No Abstract] [Full Text] [Related]
3. Poliomyelitis vaccines: killed or live?
Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
[No Abstract] [Full Text] [Related]
4. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
[TBL] [Abstract][Full Text] [Related]
5. [Studies on new attenuated strains of type I live poliovirus vaccine. I. Development of Zhong I9 strain].
Chen TQ; Li CZ; Ni SF; Ji GF; Shi M; Ye ZZ; Guo R; Dong DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct; 5(5):280-4. PubMed ID: 6329533
[No Abstract] [Full Text] [Related]
6. Re: Laboratory tests for live attenuated poliovirus vaccine. Subhash C. Arya; Biologicals, Volume 26, pp. 245-246, 1998.
Milstien JB; Zaffran M; Wood DJ; Griffiths E
Biologicals; 1999 Sep; 27(3):277-8. PubMed ID: 10652184
[No Abstract] [Full Text] [Related]
7. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
[TBL] [Abstract][Full Text] [Related]
8. Standardization of safety and potency tests of vaccines against poliomyelitis.
Elisberg BL
Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
[No Abstract] [Full Text] [Related]
9. Murine neurovirulence studies with a chimeric poliovirus: in vivo generation of a mutant base-paired stable attenuated poliovirus.
Lee C; Young C
Microb Pathog; 1998 Oct; 25(4):215-25. PubMed ID: 9817825
[TBL] [Abstract][Full Text] [Related]
10. Poliomyelitis vaccines: an appraisal after 25 years.
Melnick JL
Compr Ther; 1980 Jan; 6(1):6-14. PubMed ID: 7357844
[No Abstract] [Full Text] [Related]
11. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
12. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
[No Abstract] [Full Text] [Related]
13. New assays for the quality control of live oral poliovirus vaccine.
Furesz J; Levenbook I
Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
[TBL] [Abstract][Full Text] [Related]
14. Inactivated vaccines based on alternatives to wild-type seed virus.
Chumakov K; Dragunsky E; Ivshina A; Enterline J; Wells V; Nomura T; Gromeier M; Wimmer E
Dev Biol (Basel); 2001; 105():171-7. PubMed ID: 11763325
[No Abstract] [Full Text] [Related]
15. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
[TBL] [Abstract][Full Text] [Related]
16. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains].
Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE
Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952
[No Abstract] [Full Text] [Related]
17. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
Assaad F
Dev Biol Stand; 1981; 47():275-82. PubMed ID: 6262152
[No Abstract] [Full Text] [Related]
18. Differential susceptibility of transgenic PVR Tg-mice to poliovirus strains with varying neurovirulence in relation with monkeys.
Arya SC
Biologicals; 1995 Jun; 23(2):191. PubMed ID: 7546663
[No Abstract] [Full Text] [Related]
19. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
20. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
Horaud F
Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
